Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2018, Article ID 6018404, 7 pages
https://doi.org/10.1155/2018/6018404
Research Article

The Effect of Propofol on Chronic Headaches in Patients Undergoing Endoscopy

1Penn State Hershey Medical Center, Department of Anesthesiology and Perioperative Medicine, Hershey, PA, USA
2Department of Neurology, University of Colorado, Aurora, CO, USA

Correspondence should be addressed to Robert Knipe; moc.liamg@epink.trebor

Received 21 June 2017; Revised 30 September 2017; Accepted 2 November 2017; Published 21 January 2018

Academic Editor: Filippo Brighina

Copyright © 2018 David Giampetro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. B. Lipton, M. E. Bigal, M. Diamond et al., “Migraine prevalence, disease burden, and the need for preventive therapy,” Neurology, vol. 68, no. 5, pp. 343–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Ware Jr., J. B. Bjorner, and M. Kosinski, “Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales,” Medical Care, vol. 38, no. 9, pp. 73–82, 2000. View at Google Scholar
  3. M. Yang, R. Rendas-Baum, S. F. Varon et al., “Validation of the headache impact test (HIT-6) across episodic and chronic migraine,” Cephalgia, vol. 31, no. 3, pp. 357–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. G. Rhee, R. A. Bechtol, I. M. Harris, and R. Rodriguez, “Gender differences in the use of complementary and alternative medicine in adults with migraines/severe headaches in the United States,” Value in Health, vol. 16, no. 3, p. A67, 2016. View at Publisher · View at Google Scholar
  5. M. Kosinski, M. S. Bayliss, J. B. Bjorner et al., “A six-item short-form survey for measuring headache impact: the HIT-6,” Quality of Life Research, vol. 12, no. 8, pp. 963–974, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. B. K. Rasmussen, “Epidemiology of migraine,” Biomedicine & Pharmacotherapy, vol. 49, no. 10, pp. 452–455, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Lipton, S. Diamond, M. Reed et al., “Migraine diagnosis and treatment: results from the American Migraine Study II,” Headache, vol. 41, pp. 638–645, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Mendes, S. D. Silberstein, W. B. Young, T. D. Rozen, and M. F. Paolone, “Intravenous propofol in the treatment of refractory headache,” Headache, vol. 42, no. 7, pp. 638–641, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. K. E. Waldie, J. Buckley, P. N. Bull, and R. Poulton, “Tension-type headache: a life-course review,” Journal of Headache & Pain Management, vol. 1, no. 1, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  10. J. Olesen, M. G. Bousser, H. C. Diener et al., “Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine,” Cephalalgia, vol. 26, pp. 742–746, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Ahmed, R. Parthasarathy, and M. Khalil, “Chronic daily headaches,” Annals of Indian Academy of Neurology, vol. 15, no. 5, pp. S40–S50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Krusz, V. Scott, and J. Belanger, “Intravenous propofol: unique effectiveness in treating intractable migraine,” Headache, vol. 40, no. 3, pp. 224–230, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. E. V. De Diego and M. Lanteri-Minet, “Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT),” Cephalalgia, vol. 25, no. 3, pp. 184–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Mohseni and F. Fatehi, “Propofol alleviates intractable migraine headache: a case report,” Anesthesiology and Pain Medicine, vol. 2, no. 2, pp. 94–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Soleimanpour, A. Taheraghdam, R. R. Ghafouri, A. Taghizadieh, K. Marjany, and M. Soleimanpour, “Improvement of refractory migraine headache by propofol: case series,” International Journal of Emergency Medicine, vol. 5, no. 1, p. 19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Soleimanpour, R. R. Ghafouri, A. Taheraghdam et al., “Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial,” BMC Neurology, vol. 12, no. 1, pp. 114–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Drummond-Lewis and C. Scher, “Propofol: a new treatment strategy for refractory migraine headache,” Pain Medicine, vol. 3, no. 4, pp. 366–369, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Moshtaghion, N. Heiranizadeh, A. Rahimdel, A. Esmaeili, H. Hashemian, and S. Hekmatimoghaddam, “The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double blind clinical trial,” Pain Practice, vol. 15, no. 8, pp. 701–705, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Mosier, G. Roper, D. Hays, and J. Guisto, “Sedative dosing of propofol for treatment of migraine headache in the emergency department: a case series,” Western Journal of Emergency Medicine, vol. 14, no. 6, pp. 646–649, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. D. I. Ward, R. Mulcahy, P. Bailey, and D. Morgan, “Use of intravenous propofol in the treatment of migraine headache,” Emergency Medicine Australasia, vol. 25, no. 6, p. 619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Bloomstone, “Propofol: a novel treatment for breaking migraine headache,” Anesthesiology, vol. 106, no. 2, pp. 405-406, 2007. View at Publisher · View at Google Scholar
  22. P. Roffey and D. Thangathurai, “Propofol in the treatment of presurgical headache and nausea,” Journal of Head and Face Pain, vol. 42, p. 327, 2002. View at Publisher · View at Google Scholar
  23. M. J. Marmura and S. W. Goldberg, “Inpatient management of migraine,” Current Neurology and Neuroscience Reports, vol. 15, no. 4, p. 13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Cammarata, J. Cagle, and J. C. Krusz, “IV lidocaine: effective treatment for refractory migraine in the clinic,” Headache, vol. 47, pp. 755-756, 2007. View at Google Scholar
  25. A. D. Baddeley and G. Hitch, “The recency effect: implicit learning with explicit retrieval,” Memory & Cognition, vol. 21, no. 2, pp. 146–155, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Galea and M. Tracy, “Participation rates in epidemiologic studies,” Annals of Epidemiology, vol. 17, no. 9, pp. 643–653, 2007. View at Publisher · View at Google Scholar · View at Scopus